Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290
Leber congenital amaurosis (LCA) is the most severe form of inherited retinal degeneration, with an onset in the first year of life. The most frequent mutation that causes LCA, present in at least 10% of individuals with LCA from North-American and Northern-European descent, is an intronic mutation...
Saved in:
Main Authors: | Rob WJ Collin (Author), Anneke I den Hollander (Author), Saskia D van der Velde-Visser (Author), Jeannette Bennicelli (Author), Jean Bennett (Author), Frans PM Cremers (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation
by: Xavier Gerard, et al.
Published: (2012) -
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA
by: Scott J. Dooley, et al.
Published: (2018) -
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
by: Kalyan Dulla, et al.
Published: (2018) -
Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing
by: Dong Hyun Jo, et al.
Published: (2023) -
Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis
by: Da Sun, et al.
Published: (2017)